Video

Dr. Butowski on Real-Time Imaging of Nanoliposomal Irinotecan Injection

Nicholas A. Butowski, MD, discusses an early-stage study of convection-enhanced delivery of nanoliposomal irinotecan with real-time imaging.

Nicholas A. Butowski, MD, director, Translational Research in Neuro-Oncology, University of California, San Francisco, discusses an early-stage study of convection-enhanced delivery of nanoliposomal irinotecan with real-time imaging. These findings were reported on at the 2015 Annual Meeting of the Society for Neuro-Oncology.

Imaging a patient during injection has two benefits: a physician can make sure the target is being hit and can also correct any problems that might arise. Prior studies have used convection-enhanced delivery, Butowski says, but have not paired it with real-time imaging.

In this phase I study, researchers sought out to prove safety of the method.

Butowski hopes to take the strategy to the next level, though, by enhancing the delivery and reducing cost.

<<<

View more from the 2015 SNO Meeting

Related Videos
Paolo Caimi, MD
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD
Benjamin P. Levy, MD, with Kristie Kahl and Andrew Svonavec
Binod Dhakal, MD
Jill Corre, PharmD, PhD
Saad Z. Usmani, MD, MBA, FACP, FASCO